第一单位：
Hypertension League, Porto Alegre, Brazil.
作者：
Eduardo,Barbosa [1]
;
Bruna,Eibel [2]
;
Audes D M,Feitosa [3]
;
Andréa A,Brandão [4]
;
Luiz A,Bortolotto [5]
;
Mario F T,Neves [6]
;
José F V,Martin [7]
;
Antonio C S,Spinelli [8]
;
Elizabeth E S,Cestário [9]
;
Erika M G,Campana [10]
;
Juan C Y,Toledo [7]
;
Rui M S,Póvoa [11]
;
Thomas,Beaney [12]
;
Anca Chis,Ster [13]
;
Neil R,Poulter [13]
;
Marco A,Mota-Gomes [14]
;
Weimar Kunz Sebba,Barroso [15]
作者单位：
Hypertension League, Porto Alegre, Brazil.
[1]
Hypertension League, Porto Alegre, Brazil.;Post Graduation Program IC/FUC, Porto Alegre, Brazil.
[2]
Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Recife, Brazil.
[3]
State University of Rio de Janeiro, Rio de Janeiro, Brazil.
[4]
InstitUto do Coração - InCor - HC FMUSP, Brazil.
[5]
Department of Clinical Medicine State, University of Rio de Janeiro, Rio de Janeiro, Brazil.
[6]
Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
[7]
Cardiocentro, Natal, Brazil.
[8]
Centro Universitário de Votuporanga, Votuporanga, Brazil.
[9]
Universidade Nova Iguaçu (UNIG), Nova Iguaçu, Rio de Janeiro, Brazil.
[10]
Universidade Federal de São Paulo, São Paulo, Brazil.
[11]
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.;Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.
[12]
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
[13]
Department of Cardiology, CESMAC/Uncisal, Hospital do Coração de Alagoas, Maceió, Brazil.
[14]
Hypertension League, Federal University of Goias, Goias, Brazil.
[15]
DOI
10.1093/eurheartj/suaa022
PMID
32884462
发布时间
2023-11-12
换一批
